Complement Anaphylatoxin Receptors in Inflammation
补充炎症中的过敏毒素受体
基本信息
- 批准号:6326508
- 负责人:
- 金额:$ 29.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 2006-02-28
- 项目状态:已结题
- 来源:
- 关键词:anaphylatoxins complement complement deficiency complement receptor cytokine dermatitis flow cytometry genetically modified animals immune complex diseases immunofluorescence technique inflammation laboratory mouse molecular pathology pemphigus peritonitis polymerase chain reaction receptor expression septic shock tissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): One of the major biological consequences
of complement activation is the generation of three small cationic peptides
C3a, C4a, and C5a, collectively referred to as complement anaphylatoxins. The
complement anaphylatoxins are potent proinflammatory molecules that mediate
numerous biological functions by binding to seven transmembrane G-protein
coupled receptors expressed on specific target cells. The acute and chronic
overproduction of complement anaphylatoxin peptides is considered to be a major
contributor to the pathogenesis of numerous diseases, including rheumatoid
arthritis, psoriasis, septic shock, myocardial ischemic injury, acute
respiratory distress syndrome, and multiple system organ failure. The goal of
this research program is to increase our understanding of the specific and
overall roles that complement anaphylatoxin peptides and their receptors play
in inflammation and immunity. During the next several years, the cellular
expression and biological functions mediated by the C3a receptor will be
examined in detail. In addition, the in vivo biological role of the C3a
receptor will be studied and evaluated using a C3a receptor "knock-out" mouse
in several well-characterized models of inflammation, infection, and
autoimmunity. These studies will be accomplished by four major specific aims:
1) to determine the cells in peripheral blood and selected tissues that express
the C3a anaphylatoxin receptor, and to delineate C3a mediated biological
functions by cells expressing the C3a receptor, 2) to determine the effect of
C3a receptor deficiency on pulmonary inflammation in established models of
immune-complex injury, asthma, and bacterial infection and clearance, 3) to
determine the effect of C3a receptor deficiency in the skin using established
models of infectious dermatitis, immune-complex injury, and bullous pemphigoid,
and 4) to determine the effect of C3a receptor deficiency in the peritoneum
using established models of immune-complex peritonitis, acute septic
peritonitis, and septic shock.
描述(由申请人提供):主要生物后果之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICK A. WETSEL其他文献
RICK A. WETSEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICK A. WETSEL', 18)}}的其他基金
Cross-Regulation of Atherosclerosis and Autoimmunity
动脉粥样硬化和自身免疫的交叉调节
- 批准号:
8761633 - 财政年份:2014
- 资助金额:
$ 29.9万 - 项目类别:
Cross-Regulation of Atherosclerosis and Autoimmunity
动脉粥样硬化和自身免疫的交叉调节
- 批准号:
8891486 - 财政年份:2014
- 资助金额:
$ 29.9万 - 项目类别:
Mouse C4b-binding Protein in Adaptive Immunity
适应性免疫中的小鼠 C4b 结合蛋白
- 批准号:
7426383 - 财政年份:2006
- 资助金额:
$ 29.9万 - 项目类别:
Mouse C4b-binding Protein in Adaptive Immunity
适应性免疫中的小鼠 C4b 结合蛋白
- 批准号:
7076292 - 财政年份:2006
- 资助金额:
$ 29.9万 - 项目类别:
相似国自然基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the role of complement component 5a in ANCA-associated vasculitis
研究补体成分 5a 在 ANCA 相关血管炎中的作用
- 批准号:
MR/Y000854/1 - 财政年份:2024
- 资助金额:
$ 29.9万 - 项目类别:
Fellowship
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 29.9万 - 项目类别:
NSF Convergence Accelerator, Track M: TANDEM: Tensegrity-based Assistive aND rehabilitation Exosuits to complement human bioMechanics
NSF 融合加速器,轨道 M:TANDEM:基于张拉整体的辅助和康复外装,以补充人体生物力学
- 批准号:
2344385 - 财政年份:2024
- 资助金额:
$ 29.9万 - 项目类别:
Standard Grant
Development of a novel oral vaccine for fish: Synergy of chitosan nano particle and complement-mediated opsonization
新型鱼类口服疫苗的开发:壳聚糖纳米颗粒与补体介导的调理作用的协同作用
- 批准号:
24K17960 - 财政年份:2024
- 资助金额:
$ 29.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Crosstalk between purinergic signaling and the complement system in sepsis-induced immunosuppression.
脓毒症引起的免疫抑制中嘌呤能信号传导与补体系统之间的串扰。
- 批准号:
23H03013 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
- 批准号:
10629550 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection
定义蜱唾液抑制补体对蜱传病毒进化和小鼠感染模型适应性免疫反应的影响
- 批准号:
10535945 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
急性至持续性风疹病毒感染期间获得的补体耐药性
- 批准号:
10645486 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
VCP 抑制补体途径治疗阿尔茨海默病
- 批准号:
10602757 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别: